STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $188,358,000 | -54.8% | 38,917 | -0.7% | 0.00% | – |
| Q4 2019 | $416,803,000 | +27.2% | 39,210 | +24.6% | 0.00% | – |
| Q3 2019 | $327,551,000 | +20.2% | 31,465 | +76.9% | 0.00% | – |
| Q2 2019 | $272,497,000 | +19.2% | 17,787 | 0.0% | 0.00% | – |
| Q1 2019 | $228,563,000 | +12762.3% | 17,787 | +9411.8% | 0.00% | – |
| Q4 2018 | $1,777,000 | -42.8% | 187 | 0.0% | 0.00% | – |
| Q3 2018 | $3,104,000 | +3.4% | 187 | 0.0% | 0.00% | – |
| Q2 2018 | $3,001,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |